Cytokinetics Inc (CYTK)
Quick ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Cash | US$ in thousands | 113,024 | 65,582 | 112,666 | 82,985 | 36,433 |
Short-term investments | US$ in thousands | 542,376 | 763,718 | 511,034 | 418,015 | 231,367 |
Receivables | US$ in thousands | 1,283 | 147 | 51,819 | 4,420 | 5,163 |
Total current liabilities | US$ in thousands | 102,678 | 84,617 | 71,860 | 31,199 | 26,023 |
Quick ratio | 6.40 | 9.80 | 9.40 | 16.20 | 10.49 |
December 31, 2023 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($113,024K
+ $542,376K
+ $1,283K)
÷ $102,678K
= 6.40
The quick ratio of Cytokinetics Inc has shown fluctuations over the past five years. The ratio decreased from 8.98 in 2019 to 6.12 in 2023, exhibiting a downward trend. Despite this decrease, the company's quick ratio remains above 1, indicating its ability to cover immediate liabilities with its most liquid assets. The highest quick ratio was recorded in 2020 at 15.20, suggesting a strong liquidity position that year. Overall, Cytokinetics Inc has maintained a healthy quick ratio throughout the years, signaling its ability to meet short-term obligations efficiently.
Peer comparison
Dec 31, 2023